Pacer Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-204,676
Closed -$6.02M 3946
2025
Q2
$6.02M Sell
204,676
-96,862
-32% -$2.9M 0.02% 631
2025
Q1
$10.5M Buy
+301,538
New +$12M 0.02% 468
2024
Q4
Sell
-1,246,520
Closed -$54.3M 3721
2024
Q3
$54.3M Sell
1,246,520
-823,914
-40% -$31M 0.11% 200
2024
Q2
$56M Buy
2,070,434
+508,789
+33% +$14.7M 0.13% 192
2024
Q1
$45.6M Buy
1,561,645
+503,618
+48% +$15.3M 0.1% 211
2023
Q4
$39.8M Buy
1,058,027
+1,057,698
+321,489% +$38.9M 0.11% 201
2023
Q3
$14.8K Sell
329
-9,131
-97% -$553K ﹤0.01% 2548
2023
Q2
$697K Buy
9,460
+5,760
+156% +$389K ﹤0.01% 1319
2023
Q1
$217K Sell
3,700
-4,838
-57% -$267K ﹤0.01% 1356
2022
Q4
$430K Buy
+8,538
New +$513K ﹤0.01% 1379

Other funds holding OMCL

Pacer Advisors's OMCL Position: Q3 2025 in Review

Pacer Advisors sold out of Omnicell (OMCL) in Q3 2025, closing a stake of 204,676 shares — an estimated $6.02M sold.

Pacer Advisors first reported a position in OMCL in Q4 2022 and held it in 10 quarters. The position peaked at $56M in Q2 2024. 259 funds tracked by Wall St. Rank hold OMCL as of Q3 2025.

  • Pacer Advisors reported no remaining Omnicell position as of Q3 2025 after selling out during the quarter.
  • Pacer Advisors sold 204,676 Omnicell shares in Q3 2025, an estimated $6.02M.
  • Pacer Advisors first reported a position in Omnicell in Q4 2022 and held it in 10 quarters.
  • Pacer Advisors's Omnicell position peaked at $56M in Q2 2024.
  • 259 funds tracked by Wall St. Rank held Omnicell as of Q3 2025.

Based on Pacer Advisors's 13F filing for Q3 2025, filed 15 Oct 2025.